Rare flu mutation might lead to new vaccine : futurity

as declared in futurity

Rare flu mutation might lead to new vaccine

Rare flu mutation might lead to new vaccine

Share Article FacebookTwitterEmail You are free to share this article under the Attribution 4.0 International license.Follow Futurity RSSTwitterFacebookNewsletterA rare and improbable mutation in a protein encoded by an influenza virus makes it unable to defend itself against the body's immune system.Scientists say the discovery could provide a new strategy for live influenza vaccines in the future.


not to mention umn

WHO switches H1N1 in Southern Hemisphere flu vaccine

WHO switches H1N1 in Southern Hemisphere flu vaccine

World Health Organization (WHO) vaccine advisors today recommended changing only the 2009 H1N1 component for the Southern Hemisphere's 2017 flu vaccine, the first change in the H1N1 component since the former pandemic virus became a globally circulating seasonal flu strain.The newly recommended H1N1 vaccine strain, called A/Michigan/45/2015 replaces the longstanding A/California/7/2009 and is recommended to improve protection against two subclades that have emerged over the past season.However, the seasonal flu vaccines for the Northern Hemisphere, based in the WHO group's recommendation last February, still contain the A/California/7/2009 vaccine strain.


in the same way umn

US officials hope for improved flu vaccine uptake

US officials hope for improved flu vaccine uptake

In an annual push to build awareness and support for seasonal flu vaccination today, US health officials said they hoped the absence of the inhaled flu vaccine doesn't erode steadily rising immunization rates in kids and noted rising uptake in healthcare personnel, especially those working in long-term care settings.Experts, including Centers for Disease Control and Prevention (CDC) Director Tom Frieden, MD, MPH, spoke at a media briefing hosted by the National Foundation for Infectious Diseases (NFID).Now in its 20th year, the NFID event typically sketches out the lay of the land with flu vaccine developments and officials' views of how upcoming flu season could unfold.